An observational case-cohort study conducted by Bansal N. et al. demonstrated that rising levels of NT-proBNP over two years were significantly linked to increased risks of both HF and atrial fibrillation, while elevated sST2 was associated with HF, suggesting potential biomarkers for cardiovascular risk in CKD patients [45]. The gene discussed is NPPB; the disease is chronic kidney disease.